Accelerating the discovery of a cure for ALS.

< Home

ALS Patients Needed to Test ALS Biomarker Device
Posted on: February 24, 2013

The Winning Technology of Prize4Life's $1M Biomarker Prize to Be Evaluated in New Research Study

In 2011, Prize4Life awarded its $1M ALS Biomarker Prize to Dr. Seward Rutkove for his discovery of a biomarker for ALS - a technology called electrical impedance myography (EIM).  EIM sensitively measures the flow of a small electrical current through muscle tissue. The current travels differently through healthy and diseased tissue, and by comparing the size and speed of the electrical current, EIM can accurately measure ALS progression. EIM is non-invasive and totally painless and involves only the application of a small sensor pad to a muscle and the measurement of its electrical properties.

Convergence Medical Devices, a start-up company founded by Dr. Rutkove, is currently conducting a study in patients with ALS to help further develop and refine their EIM device for the purposes of assessing ALS in future clinical trials.  The study involves a single 45-minute visit to Convergence's headquarters in Boston, Massachusetts where a nurse practitioner will perform basic EIM measurements on muscles in the arm, leg, neck, and back.

For more information on this study or if you are interested in participating, please contact Convergence Medical Devices at or call 888.382.8824 ext.108.

The facilities are wheelchair accessible and parking is free.  All participants will be reimbursed for their time.